New strategies for antiretroviral treatment in HIV-infected patients;Nouvelles stratégies de traitement antirétroviral chez les patients infectés par le VIH

Pathologie Biologie

Volumn 49, Issue 1, 2001, Pages 67-71

  Garrait, V ^a   Molina, J M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Antiproteases; Antiretroviral therapy; HIV; Non nucleosid inhibitors; Recommendations; Viral load

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; VIRUS DETECTION; VIRUS LOAD; VIRUS RESISTANCE;

EID: 0035113775     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(00)00003-1     Document Type: Review

References (25)

1. Randomised placebo-controlled trial of ritonavir in advanced HIV-I disease
2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter
3. Surveillance du SIDA en France. Situation au 30 Juin 1998
4. Prise en charge thérapeutique des personnes infectées par le VIH
5. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection
6. Mesure de la charge virale dans le suivi des patients atteints par le VIH. Méthodes et indications
7. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
8. The ALBI trial: A randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus
9. 3 despite effective HAART
10. Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV disease
11. Drug resistance genotyping in HIV-1 therapy: The Viradapt randomised controlled trial
12. Virological and immunological response to mega-HAART salvage therapy after failure of multiple antiretroviral regimen
13. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
14. Étude cas-témoins sur les séroconversion VIH chez le personnel de santé après exposition percutanée à du sang contaminé. États-Unis, France et Royaume-Uni, janvier 1988-août 1994
15. A case-control study of HIV seroconversion in health care workers after percutaneous exposure
16. Maternal viral load, zidovudine treatment and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
17. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1- A meta-analysis of 15 prospective cohort studies
18. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
19. A syndrom of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
20. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine and indinavir in previously untreated HIV-1-infected patients
21. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
22. Ziagen/Combivir is equivalent to Indinavir/Combivir in antiretroviral therapy naïve adults at 24 weeks (CNA 3005)
23. Mechanisms of virological failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, Trilège (ANRS 092)
24. Ritonavir and saquinavir combination therapy for the treatment of HIV infection
25. Indinavir can be taken with regular meals when administered with ritonavir